湖北医科大学喻伦银副教授等承担的湖北省科委“八五”重点科技项目“肺癌组织pss蛋白表达与临床相关性的研究”，近日通过了专家鉴定。该研究首次运用免疫组织化学方法较大样本系统观察了P53基因突变与人类肺癌发生、细胞增殖、癌组织类型及分级、肿瘤临床分期和患者预后的关 Hubei University of Science and Technology, Professor Yulun Lun, and other experts on Hubei Province Science and Technology Committee’s “Eighth Five-Year Plan” key science and technology project “Pss protein expression and clinical relevance of lung cancer research,” recently passed the expert appraisal. For the first time, a large sample system of immunohistochemistry was used to observe the relationship between P53 gene mutations and the development of human lung cancer, cell proliferation, type and grade of cancer tissues, clinical stage of tumors, and prognosis of patients.